These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 36221407

  • 1. The likelihood approach for potential role of "GABRG2 (C588T, C315T) gene polymorphisms" on the poor response to carbamazepine therapy in Pakhtun population of Pakistan.
    Ullah S, Ali N, Ahmad S, Sha SWA, Ali S, Almarshad F.
    Medicine (Baltimore); 2022 Oct 07; 101(40):e30948. PubMed ID: 36221407
    [Abstract] [Full Text] [Related]

  • 2. Vitamin B6 and homocysteine levels in carbamazepine treated epilepsy of Khyber Pakhtunkhwa.
    Shakir S, Ali N, Udin Z, Nazish H, Nabi M.
    Afr Health Sci; 2017 Jun 07; 17(2):559-565. PubMed ID: 29062354
    [Abstract] [Full Text] [Related]

  • 3. Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption.
    Ponnala S, Chaudhari JR, Jaleel MA, Bhiladvala D, Kaipa PR, Das UN, Hasan Q.
    Genet Test Mol Biomarkers; 2012 Jun 07; 16(6):550-7. PubMed ID: 22239287
    [Abstract] [Full Text] [Related]

  • 4. GABRG2 C588T Polymorphism Is Associated with Idiopathic Generalized Epilepsy but Not with Antiepileptic Drug Resistance in Pakistani Cohort.
    Saleem T, Maqbool H, Sheikh N, Tayyeb A, Mukhtar M, Ashfaq A.
    Biomed Res Int; 2022 Jun 07; 2022():3460792. PubMed ID: 36425336
    [Abstract] [Full Text] [Related]

  • 5. Analysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatment.
    Wang S, Zhang X, Zhou L, Wu Q, Han Y.
    Clin Transl Sci; 2021 Sep 07; 14(5):1725-1733. PubMed ID: 33650258
    [Abstract] [Full Text] [Related]

  • 6. GABRG2 C588T gene polymorphisms might be a predictive genetic marker of febrile seizures and generalized recurrent seizures: a case-control study in a Romanian pediatric population.
    Butilă AT, Zazgyva A, Sin AI, Szabo ER, Tilinca MC.
    Arch Med Sci; 2018 Jan 07; 14(1):157-166. PubMed ID: 29379546
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of EPHX1 c.337 T>C and UGT2B7*2 genetic polymorphisms on the requirement of carbamazepine maintenance dose in persons with epilepsy (PWE) of Southern part of India: a cross-sectional genetic association study.
    Venkatraman S, Ramasamy K, Nair PP, Rajendran P.
    Drug Metab Pers Ther; 2023 Jun 01; 38(2):191-197. PubMed ID: 36853909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutation Screening of the γ-Aminobutyric Acid Type-A Receptor Subunit γ2 Gene in Korean Patients with Childhood Absence Epilepsy.
    Kim YO, Kim MK, Nam TS, Jang SY, Park KW, Kim EY, Rho YI, Woo YJ.
    J Clin Neurol; 2012 Dec 01; 8(4):271-5. PubMed ID: 23323135
    [Abstract] [Full Text] [Related]

  • 13. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
    Daci A, Beretta G, Vllasaliu D, Shala A, Govori V, Norata GD, Krasniqi S.
    PLoS One; 2015 Dec 01; 10(11):e0142408. PubMed ID: 26555147
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.
    Kananura C, Haug K, Sander T, Runge U, Gu W, Hallmann K, Rebstock J, Heils A, Steinlein OK.
    Arch Neurol; 2002 Jul 01; 59(7):1137-41. PubMed ID: 12117362
    [Abstract] [Full Text] [Related]

  • 16. The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy.
    Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L.
    Neuropsychiatr Dis Treat; 2012 Jul 01; 8():191-6. PubMed ID: 22570551
    [Abstract] [Full Text] [Related]

  • 17. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ, Marson AG, Weston J, Tudur Smith C.
    Cochrane Database Syst Rev; 2015 Jul 23; (7):CD001904. PubMed ID: 26204241
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.